Results 251 to 260 of about 765,049 (358)

Clinician opinions on starting treatment for opportunistic infection prevention in interstitial lung disease: the STOP-ILD study

ERJ Open Research
Jack Evans, Nicholas D. Weatherley, Stephen M. Bianchi   +2 more
doaj   +1 more source

An Investigation of Hyperostosis Frontalis Interna in a Modern Anatomical Body Donor Population

Clinical Anatomy, EarlyView.
ABSTRACT This research sought to examine the prevalence and severity of hyperostosis frontalis interna (HFI) in the Chicagoland anatomical body donor population. The study further aimed to elucidate potential demographic risk factors for HFI, including sex, age at death, and structural vulnerability index (SVI), as well as any common comorbidities, as ...
Amy C. Beresheim, Amanda Hall
wiley   +1 more source

Pulmonary Complications in Connective Tissue Disease-Associated Interstitial Lung Disease. [PDF]

Clin Respir J
Lewandowska AA, Waśniowska D, Rybacki C, Graczyk M, Duszyńska O, Mirus-Arabik H, Gaczkowska A, Kołodziej M.   +7 more
europepmc   +1 more source

CD24 is a promising immunotherapeutic target for enhancing efficacy of third‐generation EGFR‐TKIs on EGFR‐mutated lung cancer

Cancer Communications, EarlyView.
Abstract Background Third‐generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) show initial efficacy in EGFR‐mutated lung cancer, but residual disease persists. This study aimed to investigate cluster of differentiation 24 (CD24) as a translational immunotherapeutic target for enhancing third‐generation EGFR‐TKI efficacy.
Jiaqi Liang, Guoshu Bi, Xiaolong Huang, Zhijie Xu, Yiwei Huang, Yunyi Bian, Guangyao Shan, Wei Guo, Yuanliang Yan, Qihai Sui, Xiaodong Yang, Zhencong Chen, Tao Lu, Huan Zhang, Qun Wang, Wei Jiang, Cheng Zhan   +16 more
wiley   +1 more source

Understanding cystic lung lesions in smokers with interstitial lung disease: radiologic-pathological correlation. [PDF]

Insights Imaging
Arenas-Jiménez JJ, Aranda I, Shalygina S, Alenda C, Ferrandez-Ferrandez D, García-Garrigós E.   +5 more
europepmc   +1 more source

Nephroprotective Potential of Olea europaea Leaf Extract Against Combined Noise and Toluene‐Induced Oxidative and Histopathological Renal Injuries in Wistar Rats

Chemistry &Biodiversity, EarlyView.
ABSTRACT Noise and toluene are environmental stressors that induce oxidative stress and inflammation, contributing to renal dysfunction. This study evaluated the protective effects of Olea europaea leaf extract (OeLE; 40 mg/kg/day) against combined noise‐ and toluene‐induced nephrotoxicity in Wistar rats.
Takoua Ben Attia, Mabrouk Horchani, Mariem Salhi, Zeineb Dhifallah, Meriem Ksentini, Hichem Ben Jannet, Abada Mhamdi   +6 more
wiley   +1 more source

<i>Tropheryma whipplei</i> in interstitial lung disease: A case series. [PDF]

Respir Med Case Rep
Li J, Guo B, Zhao G, Wei R, Luo Q, Zhuo C, Han Q.   +6 more
europepmc   +1 more source

Response to "complexity of interstitial lung disease disproportionality signal analysis in pharmacovigilance databases". [PDF]

EClinicalMedicine
Zhu Z, Li Y, Zhao J.
europepmc   +1 more source

Model‐Informed Drug Development Applications and Opportunities in mRNA‐LNP Therapeutics

Clinical Pharmacology &Therapeutics, EarlyView.
The utilization of lipid nanoparticles (LNP) for encapsulating mRNA has revolutionized the field of therapeutics, enabling the rapid development of COVID‐19 vaccines and cancer vaccines. However, the clinical development of mRNA‐LNP therapeutics faces numerous challenges due to their complex mechanisms of action and limited clinical experience.
Jiawei Zhou, Rohit Rao, Monica E. Shapiro, Nessy Tania, Cody Herron, Cynthia J. Musante, Jim H. Hughes   +6 more
wiley   +1 more source

To B or Not to B: Germinal Center Responses in Progressive Fibrotic Interstitial Lung Disease. [PDF]

Am J Respir Crit Care Med
Sherman A, Medoff BD, Cho JL.
europepmc   +1 more source